Once weekly paclitaxel associated with a fixed dose of oral metronomic cyclophosphamide: a dose-finding phase 1 trial
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Once weekly paclitaxel associated with a fixed dose of oral metronomic cyclophosphamide: a dose-finding phase 1 trial ; volume:18 ; number:1 ; day:31 ; month:7 ; year:2018 ; pages:1-7 ; date:12.2018
BMC cancer ; 18, Heft 1 (31.7.2018), 1-7, 12.2018
- Creator
-
Pannier, Diane
- Contributor
-
Adenis, Antoine
Bogart, Emilie
Dansin, Eric
Clisant-Delaine, Stéphanie
Decoupigny, Emilie
Lesoin, Anne
Amela, Eric
Ducornet, Sandrine
Meurant, Jean-Pierre
Le Deley, Marie-Cécile
Penel, Nicolas
SpringerLink (Online service)
- DOI
-
10.1186/s12885-018-4678-x
- URN
-
urn:nbn:de:101:1-2018100221340177529628
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Pannier, Diane
- Adenis, Antoine
- Bogart, Emilie
- Dansin, Eric
- Clisant-Delaine, Stéphanie
- Decoupigny, Emilie
- Lesoin, Anne
- Amela, Eric
- Ducornet, Sandrine
- Meurant, Jean-Pierre
- Le Deley, Marie-Cécile
- Penel, Nicolas
- SpringerLink (Online service)
Other Objects (12)
Dose-dependent effect of cyclophosphamide treatment on actin
Sustained platelet-sparing effect of weekly low dose paclitaxel allows effective, tolerable delivery of extended dose dense weekly carboplatin in platinum resistant/refractory epithelial ovarian cancer
Weekly versus biweekly high-dose rate brachytherapy schedules in carcinoma cervix following concomitant chemoradiation with paclitaxel and carboplatin
VEGFR2 heterogeneity and response to anti-angiogenic low dose metronomic cyclophosphamide treatment
Weekly paclitaxel in escalating doses in a patient with anthracycline-resistant, triple-negative, metastatic breast cancer with severe liver dysfunction
Phase Ib Dose-Finding Study of Varlitinib Combined with Weekly Paclitaxel With or Without Carboplatin ± Trastuzumab in Advanced Solid Tumors
Impact of regular physical activity on weekly warfarin dose requirement
Maximum Tolerated Dose and Pharmacokinetics of Paclitaxel Micellar in Patients with Recurrent Malignant Solid Tumours: A Dose-Escalation Study
High- and low-dose cyclophosphamide in Egyptian lupus nephritis patients: a multicenter retrospective analysis
The Management of two Cases of “Spontaneous” Factor VIII Inhibitors with high Dose Cyclophosphamide
Hypoglycaemia frequency and physiological response after double or triple doses of once-weekly insulin icodec vs once-daily insulin glargine U100 in type 2 diabetes: a randomised crossover trial
Impaired liver function: effect on paclitaxel toxicity, dose modifications and overall survival
Dose-dependent effect of cyclophosphamide treatment on actin
Sustained platelet-sparing effect of weekly low dose paclitaxel allows effective, tolerable delivery of extended dose dense weekly carboplatin in platinum resistant/refractory epithelial ovarian cancer
Weekly versus biweekly high-dose rate brachytherapy schedules in carcinoma cervix following concomitant chemoradiation with paclitaxel and carboplatin
VEGFR2 heterogeneity and response to anti-angiogenic low dose metronomic cyclophosphamide treatment
Weekly paclitaxel in escalating doses in a patient with anthracycline-resistant, triple-negative, metastatic breast cancer with severe liver dysfunction
Phase Ib Dose-Finding Study of Varlitinib Combined with Weekly Paclitaxel With or Without Carboplatin ± Trastuzumab in Advanced Solid Tumors
Impact of regular physical activity on weekly warfarin dose requirement
Maximum Tolerated Dose and Pharmacokinetics of Paclitaxel Micellar in Patients with Recurrent Malignant Solid Tumours: A Dose-Escalation Study
High- and low-dose cyclophosphamide in Egyptian lupus nephritis patients: a multicenter retrospective analysis
The Management of two Cases of “Spontaneous” Factor VIII Inhibitors with high Dose Cyclophosphamide
Hypoglycaemia frequency and physiological response after double or triple doses of once-weekly insulin icodec vs once-daily insulin glargine U100 in type 2 diabetes: a randomised crossover trial
Impaired liver function: effect on paclitaxel toxicity, dose modifications and overall survival
Dose-dependent effect of cyclophosphamide treatment on actin
Sustained platelet-sparing effect of weekly low dose paclitaxel allows effective, tolerable delivery of extended dose dense weekly carboplatin in platinum resistant/refractory epithelial ovarian cancer
Weekly versus biweekly high-dose rate brachytherapy schedules in carcinoma cervix following concomitant chemoradiation with paclitaxel and carboplatin
VEGFR2 heterogeneity and response to anti-angiogenic low dose metronomic cyclophosphamide treatment
Weekly paclitaxel in escalating doses in a patient with anthracycline-resistant, triple-negative, metastatic breast cancer with severe liver dysfunction
Phase Ib Dose-Finding Study of Varlitinib Combined with Weekly Paclitaxel With or Without Carboplatin ± Trastuzumab in Advanced Solid Tumors
Impact of regular physical activity on weekly warfarin dose requirement
Maximum Tolerated Dose and Pharmacokinetics of Paclitaxel Micellar in Patients with Recurrent Malignant Solid Tumours: A Dose-Escalation Study
High- and low-dose cyclophosphamide in Egyptian lupus nephritis patients: a multicenter retrospective analysis
The Management of two Cases of “Spontaneous” Factor VIII Inhibitors with high Dose Cyclophosphamide
Hypoglycaemia frequency and physiological response after double or triple doses of once-weekly insulin icodec vs once-daily insulin glargine U100 in type 2 diabetes: a randomised crossover trial